ArticleRadiation oncology (London, England)2019

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience.

Maurizio Valeriani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.